• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于术前循环肿瘤细胞的可切除胃癌预测新列线图

A Novel Nomogram to Predict Resectable Gastric Cancer Based on Preoperative Circulating Tumor Cell.

机构信息

Department of Hepatic Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.

Zhongshan People's Hospital Affiliated to Guangdong Medical University, Guangdong, China.

出版信息

Clin Transl Gastroenterol. 2024 Feb 1;15(2):e00561. doi: 10.14309/ctg.0000000000000561.

DOI:10.14309/ctg.0000000000000561
PMID:36727697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10887436/
Abstract

INTRODUCTION

Circulating tumor cells (CTCs) have been suggested to have an important prognostic role in gastrointestinal tumors. We developed a preoperative CTC-based nomogram to predict the prognosis of patients with resectable gastric cancer after surgery and established a risk stratification system based on the nomogram.

METHODS

From January 2012 to June 2017, we screened 258 patients with gastric cancer treated with surgery from one center as the training cohort and 133 patients with gastric cancer treated with surgery from another as the validation cohort, screened prognostic factors for the training cohort using univariate and multivariate Cox risk proportional models, created predictive overall survival (OS) and a recurrence-free survival (RFS) nomogram, and plotted the receiver operating characteristic curve and calibration curve for this nomogram in the training and validation cohorts. Risk score stratification was performed according to the nomogram, and OS curves were plotted for the low, medium, and high-risk groups using the Kaplan-Meier method.

RESULTS

The CTC positivity rate was 78.5% in all patients. CTC, TNM stage, and Ki-67 were the prognostic factors affecting OS and RFS after gastric cancer surgery. The nomogram consisted of these 3 variables. In the training group, the area under the curve of the nomogram for OS at 1, 3, and 5 years was 0.918, 0.829, and 0.813, respectively, and the area under the curve for RFS was 0.900, 0884, and 0.839, respectively. There was a statistically significant difference in OS among the low, medium, and high-risk groups according to the risk stratification system constructed from nomogram scores ( P < 0.001).

DISCUSSION

Two nomograms based on preoperative CTC were established to predict OS and RFS after resectable gastric cancer. The 2 nomograms had good discrimination and calibration and significant stratification ability of the risk stratification system established according to them.

摘要

简介

循环肿瘤细胞(CTC)被认为在胃肠道肿瘤中有重要的预后作用。我们开发了一种基于术前 CTC 的列线图,以预测可切除胃癌患者手术后的预后,并基于该列线图建立了风险分层系统。

方法

从 2012 年 1 月至 2017 年 6 月,我们筛选了 258 名接受手术治疗的胃癌患者作为训练队列,另筛选了 133 名接受手术治疗的胃癌患者作为验证队列,使用单因素和多因素 Cox 风险比例模型筛选训练队列的预后因素,创建预测总生存期(OS)和无复发生存期(RFS)的列线图,并在训练和验证队列中绘制该列线图的接收者操作特征曲线和校准曲线。根据列线图进行风险评分分层,并使用 Kaplan-Meier 方法绘制低、中、高危组的 OS 曲线。

结果

所有患者的 CTC 阳性率为 78.5%。CTC、TNM 分期和 Ki-67 是影响胃癌手术后 OS 和 RFS 的预后因素。该列线图由这 3 个变量组成。在训练组中,OS 列线图在 1、3 和 5 年的曲线下面积分别为 0.918、0.829 和 0.813,RFS 的曲线下面积为 0.900、0.884 和 0.839。根据基于列线图评分构建的风险分层系统,低、中、高危组之间的 OS 存在统计学差异(P<0.001)。

讨论

建立了两个基于术前 CTC 的列线图,以预测可切除胃癌患者的 OS 和 RFS。这两个列线图具有良好的区分度和校准度,以及根据它们建立的风险分层系统具有显著的分层能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9414/10887436/16e80b78ff4b/ct9-15-e00561-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9414/10887436/017eb4050741/ct9-15-e00561-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9414/10887436/20f61257b8d5/ct9-15-e00561-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9414/10887436/7e85a2590e38/ct9-15-e00561-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9414/10887436/16e80b78ff4b/ct9-15-e00561-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9414/10887436/017eb4050741/ct9-15-e00561-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9414/10887436/20f61257b8d5/ct9-15-e00561-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9414/10887436/7e85a2590e38/ct9-15-e00561-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9414/10887436/16e80b78ff4b/ct9-15-e00561-g004.jpg

相似文献

1
A Novel Nomogram to Predict Resectable Gastric Cancer Based on Preoperative Circulating Tumor Cell.基于术前循环肿瘤细胞的可切除胃癌预测新列线图
Clin Transl Gastroenterol. 2024 Feb 1;15(2):e00561. doi: 10.14309/ctg.0000000000000561.
2
A nomogram to predict postoperative overall and cancer specific survival in patients with primary parotid squamous cell carcinoma: a population based study.预测原发性腮腺鳞状细胞癌患者术后总体生存率和癌症特异性生存率的列线图:一项基于人群的研究。
Sci Rep. 2025 Feb 25;15(1):6774. doi: 10.1038/s41598-025-90480-8.
3
[Risk factors and nomogram construction for predicting long-term survival in hepatoid adenocarcinoma of the stomach].[预测胃肝样腺癌长期生存的危险因素及列线图构建]
Zhonghua Wei Chang Wai Ke Za Zhi. 2025 Feb 25;28(2):157-168. doi: 10.3760/cma.j.cn441530-20240910-00312.
4
Novel nomogram and risk stratification for peritoneal recurrence after curative resection in gastric cancer.胃癌根治术后腹膜复发的新型列线图和风险分层。
Sci Rep. 2024 Aug 17;14(1):19103. doi: 10.1038/s41598-024-70349-y.
5
Prognostic impact of albumin-bilirubin score in predicting the long-term survival of distal cholangiocarcinoma after radical surgery.白蛋白-胆红素评分对预测远端胆管癌根治术后长期生存的预后影响
World J Surg Oncol. 2025 Apr 24;23(1):160. doi: 10.1186/s12957-025-03813-2.
6
Prognostic nomograms for gastric carcinoma after surgery to assist decision-making for postoperative treatment with chemotherapy cycles <9 or chemotherapy cycles ≥9.胃癌术后化疗周期<9或化疗周期≥9的预后列线图,以辅助术后化疗治疗决策。
Front Surg. 2022 Aug 26;9:916483. doi: 10.3389/fsurg.2022.916483. eCollection 2022.
7
Prognostic model for predicting recurrence in hepatocellular carcinoma patients with high systemic immune-inflammation index based on machine learning in a multicenter study.基于多中心研究的机器学习构建高全身免疫炎症指数肝癌患者复发预测的预后模型。
Front Immunol. 2024 Sep 9;15:1459740. doi: 10.3389/fimmu.2024.1459740. eCollection 2024.
8
Family history of malignant tumor is a predictor of gastric cancer prognosis: Incorporation into a nomogram.恶性肿瘤家族史是胃癌预后的预测因素:纳入列线图。
Medicine (Baltimore). 2022 Sep 2;101(35):e30141. doi: 10.1097/MD.0000000000030141.
9
Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.开发和验证一个列线图模型以预测胃贲门癌患者的预后。
Sci Rep. 2020 Aug 24;10(1):14143. doi: 10.1038/s41598-020-71146-z.
10
A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.基于检查淋巴结数量相关特征的列线图模型预测胃癌的预后并指导临床治疗。
Front Immunol. 2022 Nov 2;13:947802. doi: 10.3389/fimmu.2022.947802. eCollection 2022.

引用本文的文献

1
Role of circulating tumor DNA methylation in gastric cancer initiation and progression: A comprehensive review.循环肿瘤DNA甲基化在胃癌发生和发展中的作用:综述
World J Gastrointest Oncol. 2025 Aug 15;17(8):107412. doi: 10.4251/wjgo.v17.i8.107412.
2
Risk Factors for Postoperative Infections in Severe Traumatic Brain Injury Patients Undergoing Emergency Craniotomy.急诊开颅手术的重型颅脑损伤患者术后感染的危险因素
Ther Clin Risk Manag. 2025 May 2;21:609-619. doi: 10.2147/TCRM.S512780. eCollection 2025.
3
Comparison of prognostic outcomes between endoscopic submucosal dissection and surgical treatment for early gastric cancer: a retrospective cohort study.

本文引用的文献

1
Guiding Value of Circulating Tumor Cells for Preoperative Transcatheter Arterial Embolization in Solitary Large Hepatocellular Carcinoma: A Single-Center Retrospective Clinical Study.循环肿瘤细胞对孤立性大肝细胞癌术前经动脉化疗栓塞术的指导价值:一项单中心回顾性临床研究
Front Oncol. 2022 May 18;12:839597. doi: 10.3389/fonc.2022.839597. eCollection 2022.
2
Circulating Tumor Cell Is a Clinical Indicator of Pretransplant Radiofrequency Ablation for Patients with Hepatocellular Carcinoma.循环肿瘤细胞是肝细胞癌患者移植前射频消融的临床指标。
J Oncol. 2021 Oct 19;2021:7776389. doi: 10.1155/2021/7776389. eCollection 2021.
3
内镜黏膜下剥离术与手术治疗早期胃癌的预后比较:一项回顾性队列研究。
BMC Gastroenterol. 2024 Mar 4;24(1):98. doi: 10.1186/s12876-024-03186-y.
4
A novel immunohistochemical score predicts the postoperative prognosis of gastric cancer patients.一种新型免疫组织化学评分可预测胃癌患者的术后预后。
World J Surg Oncol. 2023 Jul 26;21(1):220. doi: 10.1186/s12957-023-03113-7.
Development and validation of pretreatment nomogram for disease-specific mortality in gastric cancer-A competing risk analysis.
胃癌疾病特异性死亡率的预处理列线图的开发和验证:竞争风险分析。
Cancer Med. 2021 Nov;10(21):7561-7571. doi: 10.1002/cam4.4279. Epub 2021 Oct 10.
4
Current treatment and recent progress in gastric cancer.胃癌的当前治疗方法和最新进展。
CA Cancer J Clin. 2021 May;71(3):264-279. doi: 10.3322/caac.21657. Epub 2021 Feb 16.
5
A Predictive Nomogram for Early Death of Metastatic Gastric Cancer: A Retrospective Study in the SEER Database and China.转移性胃癌早期死亡的预测列线图:基于监测、流行病学和最终结果(SEER)数据库及中国数据的回顾性研究
J Cancer. 2020 Jul 14;11(18):5527-5535. doi: 10.7150/jca.46563. eCollection 2020.
6
Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer.基于缺氧免疫的胃癌微环境基因特征用于风险分层的开发与验证
J Transl Med. 2020 May 14;18(1):201. doi: 10.1186/s12967-020-02366-0.
7
Comparable Cancer-Specific Mortality of Patients With Early Gastric Cancer Treated With Endoscopic Therapy vs Surgical Resection.早期胃癌患者接受内镜治疗与手术切除后的癌症特异性死亡率比较。
Clin Gastroenterol Hepatol. 2020 Nov;18(12):2824-2832.e1. doi: 10.1016/j.cgh.2020.04.085. Epub 2020 May 8.
8
PDPN is a prognostic biomarker and correlated with immune infiltrating in gastric cancer.血小板源性蛋白聚糖(PDPN)是一种预后生物标志物,与胃癌中的免疫浸润相关。
Medicine (Baltimore). 2020 May;99(19):e19957. doi: 10.1097/MD.0000000000019957.
9
Relevance of CTC Clusters in Breast Cancer Metastasis.循环肿瘤细胞簇在乳腺癌转移中的相关性。
Adv Exp Med Biol. 2020;1220:93-115. doi: 10.1007/978-3-030-35805-1_7.
10
The Changes and Clinical Significance of Preoperative and Postoperative Serum CEA and CA19-9 in Gastric Cancer.胃癌患者术前和术后血清 CEA 和 CA19-9 的变化及其临床意义。
Clin Lab. 2020 Apr 1;66(4). doi: 10.7754/Clin.Lab.2019.190732.